Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 85Lymphoma, Follicular 18Recurrence 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms, Plasma Cell 8Lymphoma 7Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Non-Hodgkin 5Neoplasms 4Lymphoma, Mantle-Cell 4Hematologic Diseases 4Smoldering Multiple Myeloma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Disease Progression 3Paraproteinemias 2Myelodysplastic Syndromes 2Disease 2Anemia 2Sezary Syndrome 1Prostatic Neoplasms 1Polycythemia Vera 1Plasmacytoma 1Neoplasm Metastasis 1Mycosis Fungoides 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

Doxorubicin 6Dexrazoxane 6Razoxane 5Vincristine 4Cyclophosphamide 4Radiotherapy 3Etoposide 3Prednisone 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Carvedilol 2Bleomycin 2schizandrin 1pegfilgrastim 1hydrocortisone hemisuccinate 1fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 1empagliflozin 1Watchful Waiting 1VAP-cyclo protocol 1Trastuzumab 1Taxes 1Tamoxifen 1Rituximab 1Ramipril 1Radiation 1Prednisolone 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cardiotoxicity × Lenalidomide × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡